Pharmos (PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Clarksterh	12/20/2004 9:36:51 AM
	Read Replies (1) of 1386

Although I am no longer interested in Pharmos as an investment, I am interested in why they failed and how. Might as well try to learn as much as possible from my failures. What I am most curious about is the ICP results (which showed efficacy across all three arms of the ph ii - even the culled arm). I suspect that they too were not positive since they probably would have had them ready at hand and would have announced good results. If the ICP results are indeed negative, then I suspect that something that cropped up on the yahoo boards recently is the culprit - they used a much purer dex (less HU-210) in the ph iii than in the ph ii. OTOH,if ICP (and more importantly CPP) did show efficacy then some very interesting questions arise as to why final outcome that the patient cares about shows nothing. The entire issue of TBI post injury damage expansion needs to be rethought. Clark

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next